Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 14 min ago
Peer-reviewedCC BY 4.0BMC Medicine

Cost-effectiveness of 20-valent versus 15-valent pneumococcal conjugate vaccines for infants in the Netherlands, taking into account indirect effects and adult vaccination

Related

  1. Recommendations for Adult Pneumococcal Vaccination in Korea: 2026 Update Incorporating the 21-Valent Pneumococcal Conjugate Vaccine.
    Joon Young Song, Ki Tae Kwon, Wan Beom Park +8
    Infection & chemotherapyPeer-reviewedCC BY-NCFull textEpidemiology & public healthEurope PMC
  2. Comparative Efficacy and Safety of 15-Valent and 13-Valent Pneumococcal Conjugate Vaccines Alone and in Combination with the 23-Valent Polysaccharide Vaccine: A Systematic Review and Meta-analysis
    Yuri Matsumoto, Takayuki Mihara, Yuko Okamoto +11
    Biological and Pharmaceutical BulletinPeer-reviewedCC BY-NCFull textEpidemiology & public healthJ-STAGE
  3. Immunogenicity of sequential conjugate and non-conjugate pneumococcal vaccination in dialysis patients and kidney transplant recipients: a 12-month serological follow-up
    Sophie Novelli, Aimé Nun, Antoine Cases +3
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textEpidemiology & public healthCrossrefEurope PMC
  4. Effectiveness of 20-valent pneumococcal conjugate vaccine against pneumococcal pneumonia hospitalizations among U.S. adults: Test-Negative Design
    A. J. Ologunowa, S. Kogut, V. L. Vrishali +2
    medRxivPreprintCC BYFull textInfectious diseasemedRxiv
  5. The immunogenicity of pneumococcal conjugate vaccinations in patients with asplenia and hyposplenia: a systematic review
    B. van Put, G. E. Loe-Sack-Sioe, L. G. Visser +3
    NPJ VaccinesPeer-reviewedCC BY 4.0Full textEpidemiology & public healthPMC
BibTeX
@article{boer2026costeffectiveness,
  title = {{Cost-effectiveness of 20-valent versus 15-valent pneumococcal conjugate vaccines for infants in the Netherlands, taking into account indirect effects and adult vaccination}},
  author = {Pieter T. de Boer and Albert Jan van Hoek and Mirjam Knol and Elisabeth A. M. Sanders and Hester E. de Melker and Jacco Wallinga and Anneke Steens},
  journal = {BMC Medicine},
  year = {2026},
  month = nov,
  doi = {10.1186/s12916-026-05378-7},
  url = {https://link.springer.com/article/10.1186/s12916-026-05378-7},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Cost-effectiveness of 20-valent versus 15-valent pneumococcal conjugate vaccines for infants in the Netherlands, taking into account indirect effects and adult vaccination
AU  - Pieter T. de Boer
AU  - Albert Jan van Hoek
AU  - Mirjam Knol
AU  - Elisabeth A. M. Sanders
AU  - Hester E. de Melker
AU  - Jacco Wallinga
AU  - Anneke Steens
PY  - 2026
DA  - 2026/11/06
JO  - BMC Medicine
DO  - 10.1186/s12916-026-05378-7
UR  - https://link.springer.com/article/10.1186/s12916-026-05378-7
SN  - 1741-7015
ER  -